Acupuncture in Osteoarthritis of the Knee

This study has been completed.
Sponsor:
Collaborator:
The German Society for Traditional Chinese Medicine (DGTCM)
Information provided by:
Heidelberg University
ClinicalTrials.gov Identifier:
NCT00325663
First received: May 12, 2006
Last updated: NA
Last verified: April 2004
History: No changes posted
  Purpose

The aim of this study was to evalute three different acupuncture techniques, including one sham control, in its effect on osteoarthitis of the knee


Condition Intervention Phase
Osteoarthritis of the Knee
Procedure: Acupuncture
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Specific and Non-Specific Effects of Acupuncture: A Double-Blinded, Randomized, Controlled Trial in Patients With Osteoarthritis of the Knee

Resource links provided by NLM:


Further study details as provided by Heidelberg University:

Primary Outcome Measures:
  • Main outcome measures: Improvement in knee flexibility according to the neutral-zero method, defining a success as improvement by 10 degrees or more.

Secondary Outcome Measures:
  • Secondary parameter: improvement in pain according to the reduced WOMAC score by 50 percent or more.

Estimated Enrollment: 125
Study Start Date: April 2004
Estimated Study Completion Date: April 2005
Detailed Description:

Background: Acupuncture is one of the most frequently used complementary therapeutic approaches in the treatment of osteoarthritis of the knee. Due to methodological shortcomings of previous randomized controlled studies, controversy persists whether the observed effects are specific to acupuncture or non-specific consequences of needling.

Objective: To compare classical Chinese acupuncture, semi-standardized modern acupuncture and non-specific needling by means of a double-blinded repeated measures cross-over design.

Intervention: Within three weeks all patients receive three treatment modalities in a random order in a double-blind study design.

Main outcome measures: Improvement in knee flexibility according to the neutral-zero method, defining a success as improvement by 10 degrees or more.

Secondary parameter: improvement in pain according to the reduced WOMAC score by 50 percent or more.

  Eligibility

Ages Eligible for Study:   35 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients above age 35
  • knee osteoarthritis grade II or III according to the Kellgren classification.

Exclusion Criteria:

  • orthopedic deformations of the knee,
  • malignant disease
  • auto-immune disorders
  • surgery including arthroscopy during the past 12 months
  • pain medication with steroids
  • physical therapy or acupuncture within the last for weeks
  • no or a pain medication in continuous dosage
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00325663

Sponsors and Collaborators
Heidelberg University
The German Society for Traditional Chinese Medicine (DGTCM)
Investigators
Principal Investigator: Max Karner, MD University Heidelberg
Study Director: Johannes Greten, MD German Society of Traditional Chinese Medicine
Study Chair: Oliver Gerlach, MD Shen-Centre for Traditional Chinese Medicine, Erlangen, Germany
Study Chair: Frank Brazkiewicz, MD Centre for Chinese Medicine, Bremen, Germany
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00325663     History of Changes
Other Study ID Numbers: AKOK1
Study First Received: May 12, 2006
Last Updated: May 12, 2006
Health Authority: Germany: Ethikkomission der Medizinischen Fakultät Heidelberg

Keywords provided by Heidelberg University:
acupuncture
double-blind
sham control
osteoarthritis
pain

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on April 16, 2014